Animal Life Sciences

Cancer is the leading cause of death among dogs and cats. Almost 50% of dogs and 33% of cats over the age of 10 will die of cancer. Billions in research dollars have been spent to improve our own health, yet progress in veterinary medicine lags years behind the scientific breakthroughs seen in human health. This innovation gap between human science and veterinary medicine costs the lives of millions of beloved pets and is the primary reason Animal Life Sciences was founded. Animal Life Sciences is a nutritional and pharmaceutical development company focused on the licensing, development and commercialization of safe and effective treatments for cats and dogs suffering from some of the most deadly diseases. We were founded by leading scientists, clinicians and executives to create health care solutions for pets based on cutting-edge human cancer technologies.

Exclusive licensee for pet market on 10 critical human drugs in development
Licensed, patent pending drugs have deployed $98 million in research
Drugs address top pet killers—leukemias, tumors, skin conditions
Healthy pet supplements developed at leading cancer research institute
E-com pet food launch planned for late 2020 into $6.8B high growth market
Founded by leading scientists; led by experienced high growth startup execs
Rare combo of veterinary medicine and pet food/supplements

If minimum  is raised:

• Product Development & Marketing: 94%
• Working Capital: 0%
• General & Administrative Expenses: 0%
• Intermediary Fee: 6%

If maximum  is raised:

• Product Development & Marketing: 56.07%
• Working Capital: 32.71%
• General & Administrative Expenses: 5.22%
• Intermediary Fee: 6%

Terry Tognietti - CEO
P&G, then in 1987 Co-Founder, Co-CEO/President of The Drypers Corp-Entrepreneur of the Year and Inc magazine cover in 1994 (fastest growing privately held company in America). ’98-current helped multiple co’s build multi-million brands.

Hughes Watler - CFO
25 yrs as CFO of public and private companies. Experience in all aspects of financial mgmt.; incl. various debt and equity. Expertise in: M & A, Financial Planning and Analysis, SEC regulations, Risk mgmt, and Internal controls.

Jonathan Camarillo - VP, Business Development
20-yr career Marine Corps officer--leadership roles incl. commanding officer and Marine Corps representative to Latin America. Awards: Meritorious Srvc Medals (2), Navy-Marine Corps Commendation x4(one combat V), Combat Action Ribbon.

Dr. Wayne Rosenkrantz - Scientific Advisory Board Member
Grad UC Davis; past Pres American Coll. Veterinary Dermatology, w/practice in Calif. Published and lectures extensively. awarded the DVM Pharmaceutical Award of Excellence and the Frank Král award for his contributions to veterinary dermatology

Dr. Arthur Swiergiel - Scientific Advisory Board Member
Dept head of Animal & Human Physiology, Univ of Gdansk, Poland. Doctorate from Sidney Sussex College of Cambridge University. Worked as a consultant for Science Diets and has authored or co-authored over two hundred scientific publications.

Price per Share: $1.00